ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,403,000 | -10.5% | 300,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $9,390,000 | -21.3% | 300,000 | -29.1% | 0.01% | -21.4% |
| Q1 2023 | $11,928,000 | +7.9% | 423,142 | 0.0% | 0.01% | +7.7% |
| Q4 2022 | $11,057,000 | +16.0% | 423,142 | -0.5% | 0.01% | +8.3% |
| Q3 2022 | $9,531,000 | -25.0% | 425,124 | -0.4% | 0.01% | -14.3% |
| Q2 2022 | $12,715,000 | +13.2% | 426,827 | 0.0% | 0.01% | +55.6% |
| Q1 2022 | $11,230,000 | +13.0% | 426,827 | -0.1% | 0.01% | +12.5% |
| Q4 2021 | $9,942,000 | -24.6% | 427,427 | 0.0% | 0.01% | -27.3% |
| Q3 2021 | $13,183,000 | +25.8% | 427,427 | 0.0% | 0.01% | +22.2% |
| Q2 2021 | $10,480,000 | +30.9% | 427,427 | -0.3% | 0.01% | -18.2% |
| Q1 2021 | $8,009,000 | -6.7% | 428,768 | -0.3% | 0.01% | -15.4% |
| Q4 2020 | $8,583,000 | +20.1% | 430,211 | -0.2% | 0.01% | +8.3% |
| Q3 2020 | $7,145,000 | -2.6% | 431,211 | +14.1% | 0.01% | -7.7% |
| Q2 2020 | $7,337,000 | +34.8% | 378,069 | +0.2% | 0.01% | +18.2% |
| Q1 2020 | $5,443,000 | -45.7% | 377,500 | -23.1% | 0.01% | -21.4% |
| Q4 2019 | $10,016,000 | +9.0% | 490,989 | +4.2% | 0.01% | -6.7% |
| Q3 2019 | $9,191,000 | -71.1% | 471,089 | -66.7% | 0.02% | -16.7% |
| Q2 2019 | $31,854,000 | +132.5% | 1,413,066 | +276.4% | 0.02% | -21.7% |
| Q1 2019 | $13,700,000 | +331.4% | 375,447 | +248.9% | 0.02% | +283.3% |
| Q4 2018 | $3,176,000 | -27.2% | 107,609 | +4.6% | 0.01% | -14.3% |
| Q3 2018 | $4,365,000 | +20.2% | 102,859 | +16.6% | 0.01% | +16.7% |
| Q2 2018 | $3,631,000 | -28.1% | 88,242 | +1.3% | 0.01% | -33.3% |
| Q1 2018 | $5,049,000 | +5.8% | 87,110 | +0.1% | 0.01% | +12.5% |
| Q4 2017 | $4,772,000 | -44.7% | 86,995 | -48.8% | 0.01% | -46.7% |
| Q3 2017 | $8,635,000 | -12.3% | 169,857 | -0.0% | 0.02% | -16.7% |
| Q2 2017 | $9,851,000 | +172.8% | 169,940 | +175.4% | 0.02% | +157.1% |
| Q1 2017 | $3,611,000 | +3.6% | 61,711 | -1.6% | 0.01% | 0.0% |
| Q4 2016 | $3,485,000 | -17.4% | 62,696 | -30.1% | 0.01% | -12.5% |
| Q3 2016 | $4,217,000 | -45.7% | 89,666 | -50.1% | 0.01% | 0.0% |
| Q2 2016 | $7,772,000 | +109.4% | 179,792 | +65.6% | 0.01% | +14.3% |
| Q1 2016 | $3,712,000 | -57.0% | 108,564 | -0.2% | 0.01% | -61.1% |
| Q4 2015 | $8,631,000 | +26.7% | 108,729 | -6.4% | 0.02% | +20.0% |
| Q3 2015 | $6,814,000 | -9.2% | 116,147 | -0.4% | 0.02% | 0.0% |
| Q2 2015 | $7,504,000 | -55.8% | 116,627 | -58.1% | 0.02% | -54.5% |
| Q1 2015 | $16,959,000 | +3.9% | 278,152 | -0.2% | 0.03% | -2.9% |
| Q4 2014 | $16,322,000 | +36.6% | 278,729 | +0.0% | 0.03% | +30.8% |
| Q3 2014 | $11,946,000 | +3.6% | 278,666 | +21.6% | 0.03% | 0.0% |
| Q2 2014 | $11,533,000 | +13.6% | 229,157 | -0.5% | 0.03% | +44.4% |
| Q1 2014 | $10,153,000 | +41.9% | 230,282 | +30.8% | 0.02% | +38.5% |
| Q4 2013 | $7,157,000 | +38.9% | 176,022 | +14.9% | 0.01% | +30.0% |
| Q3 2013 | $5,152,000 | +8.2% | 153,252 | -7.7% | 0.01% | 0.0% |
| Q2 2013 | $4,763,000 | – | 166,071 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |